KRRO

$11.93

$

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Next Earnings

2026-02-25

Beta

2.445

Average Volume

Market Cap

Last Dividend

CIK

0001703647

ISIN

US5009461089

CUSIP

500946108

CEO

Ram Aiyar

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

112

IPO Date

2019-10-03

Status

Active

Latest News

Title Headline Publisher Date
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? Korro Bio, Inc. (KRRO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Zacks Investment Research 2026-01-30 08:36:08
Korro Bio Analyst Day: KRRO-121 RNA-Editing Candidate Targets Ammonia Control in UCD and HE Korro Bio (NASDAQ: KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing therapeutic candidate the company believes could provide a new approach to controlling elevated blood ammonia in urea cycle disorders (UCD) and hepatic encephalopathy (HE). Management and invited speakers emphasized the clinical burden of hyperammonemia, limitations of current Defense World 2026-01-30 03:09:04
Korro Bio, Inc. (KRRO) Analyst/Investor Day Transcript Korro Bio, Inc. (KRRO) Analyst/Investor Day Transcript Seeking Alpha 2026-01-29 15:42:29
Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha 2026-01-20 11:46:00
Korro to Host Virtual Analyst Day on January 27, 2026 - Program to feature presentations from the company management about  KRRO-121 for the potential treatment of hyperammonemia , a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing perspectives on living with urea cycle disorder - CAMBRIDGE, Mass., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that the company will host a virtual Analyst Day on Tuesday, January 27, 2026, from 8 a.m. GlobeNewsWire 2026-01-20 08:00:00
Korro Bio (NASDAQ:KRRO) Shares Down 5.9% – Here’s What Happened Shares of Korro Bio, Inc. (NASDAQ: KRRO - Get Free Report) fell 5.9% during trading on Monday. The company traded as low as $8.62 and last traded at $8.94. 183,664 shares changed hands during mid-day trading, an increase of 3% from the average session volume of 178,249 shares. The stock had previously closed at $9.50. Defense World 2026-01-13 01:58:57
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 10:30 a.m. PT (1:30 p.m. ET). Todd Chappell, Chief Operating Officer, and Loic Vincent, Ph.D., Chief Scientific Officer, will also be participating at the conference. GlobeNewsWire 2026-01-08 08:00:00
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts Shares of Korro Bio, Inc. (NASDAQ: KRRO - Get Free Report) have been given a consensus rating of "Hold" by the ten brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating Defense World 2025-11-25 01:22:48

SEC Filings

Type Filing Date Accepted Date Link
SC 13G/A 2026-02-17 2026-02-17 View Filing
SC 13G/A 2026-02-17 2026-02-17 View Filing
SC 13G 2026-02-13 2026-02-13 View Filing
SC 13G/A 2026-02-05 2026-02-05 View Filing
4 2026-02-03 2026-02-03 View Filing
4 2026-02-03 2026-02-03 View Filing
4 2026-02-03 2026-02-03 View Filing
4 2026-02-03 2026-02-03 View Filing
4 2026-02-03 2026-02-03 View Filing
SC 13G 2026-01-30 2026-01-30 View Filing
S-8 2026-01-27 2026-01-27 View Filing
8-K 2026-01-27 2026-01-27 View Filing
8-K 2026-01-15 2026-01-15 View Filing
SC 13G 2026-01-05 2026-01-05 View Filing
8-K 2025-12-18 2025-12-18 View Filing
4 2025-12-16 2025-12-16 View Filing
4 2025-12-16 2025-12-16 View Filing
4 2025-12-16 2025-12-16 View Filing
4 2025-12-16 2025-12-16 View Filing
SC 13G/A 2025-11-14 2025-11-14 View Filing
10-Q 2025-11-12 2025-11-12 View Filing
8-K 2025-11-12 2025-11-12 View Filing
8-K 2025-10-08 2025-10-08 View Filing
SC 13G/A 2025-08-14 2025-08-14 View Filing
SC 13G/A 2025-08-14 2025-08-14 View Filing
SC 13G/A 2025-08-13 2025-08-13 View Filing
10-Q 2025-08-12 2025-08-12 View Filing
8-K 2025-08-12 2025-08-12 View Filing
8-K/A 2025-06-18 2025-06-18 View Filing
4 2025-06-12 2025-06-12 View Filing
4 2025-06-12 2025-06-12 View Filing
4 2025-06-12 2025-06-12 View Filing
4 2025-06-12 2025-06-12 View Filing
4 2025-06-12 2025-06-12 View Filing
4 2025-06-12 2025-06-12 View Filing
8-K 2025-06-11 2025-06-11 View Filing
10-Q 2025-05-07 2025-05-07 View Filing
8-K 2025-05-07 2025-05-07 View Filing
ARS 2025-04-29 2025-04-29 View Filing
DEFA14A 2025-04-29 2025-04-29 View Filing
DEF 14A 2025-04-29 2025-04-29 View Filing
4 2025-04-01 2025-04-01 View Filing
4 2025-04-01 2025-04-01 View Filing
3 2025-04-01 2025-04-01 View Filing
8-K 2025-03-27 2025-03-27 View Filing
S-8 2025-03-18 2025-03-18 View Filing
10-K 2025-03-18 2025-03-18 View Filing
8-K 2025-03-18 2025-03-18 View Filing
SC 13G/A 2025-02-14 2025-02-14 View Filing
SC 13G 2025-02-14 2025-02-14 View Filing
3 2025-02-11 2025-02-11 View Filing
8-K 2025-02-11 2025-02-11 View Filing
4 2025-02-05 2025-02-05 View Filing
SC 13G 2025-02-05 2025-02-05 View Filing
4 2025-02-05 2025-02-05 View Filing
4 2025-02-05 2025-02-05 View Filing
4 2025-02-05 2025-02-05 View Filing
4 2025-02-05 2025-02-05 View Filing
8-K 2025-01-13 2025-01-13 View Filing
424B3 2024-12-10 2024-12-10 View Filing
424B3 2024-12-10 2024-12-10 View Filing
EFFECT 2024-12-10 2024-12-10 View Filing
EFFECT 2024-12-10 2024-12-10 View Filing
EFFECT 2024-12-09 2024-12-09 View Filing
424B5 2024-12-06 2024-12-06 View Filing
POS AM 2024-12-02 2024-12-02 View Filing
POS AM 2024-12-02 2024-12-02 View Filing
S-3 2024-12-02 2024-12-02 View Filing
424B3 2024-11-21 2024-11-21 View Filing
424B3 2024-11-21 2024-11-21 View Filing
8-K 2024-11-21 2024-11-21 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
4 2024-11-12 2024-11-12 View Filing
424B3 2024-11-12 2024-11-12 View Filing
424B3 2024-11-12 2024-11-12 View Filing
10-Q 2024-11-12 2024-11-12 View Filing
8-K 2024-11-12 2024-11-12 View Filing
SC 13G/A 2024-11-12 2024-11-12 View Filing
424B3 2024-11-04 2024-11-04 View Filing
424B3 2024-11-04 2024-11-04 View Filing
8-K 2024-11-04 2024-11-04 View Filing
4 2024-10-18 2024-10-18 View Filing
424B3 2024-09-16 2024-09-16 View Filing
424B3 2024-09-16 2024-09-16 View Filing
8-K 2024-09-16 2024-09-16 View Filing
4 2024-09-03 2024-09-03 View Filing
3 2024-09-03 2024-09-03 View Filing
4 2024-08-28 2024-08-28 View Filing
3 2024-08-28 2024-08-28 View Filing
424B3 2024-08-28 2024-08-28 View Filing
424B3 2024-08-28 2024-08-28 View Filing
8-K 2024-08-28 2024-08-28 View Filing
424B3 2024-08-13 2024-08-13 View Filing
424B3 2024-08-13 2024-08-13 View Filing
10-Q 2024-08-13 2024-08-13 View Filing
8-K 2024-08-13 2024-08-13 View Filing
SC 13G/A 2024-07-12 2024-07-12 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Adaptive Wave 43.83% 1 1 0.65 0.72 23.74
Heikin Ashi Strategy 39.25% 0.92 8 0.84 0.92 19.16
Super Trend Strategy 32.77% 1.05 39 0.56 0.43 12.68
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxx xxxxxxx% xxxx x xxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxxxxxxx xxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx x
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx x
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxx% xxxx xx xxxx xxxx xxxx
xxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxx xxxx xxxxx
xxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxx xxxxx
xxxxxxxxx xxxxxxx% x xx xxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxx xxxxxxx% x x xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxx x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx x xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxx x xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x x xxxx xxxx xxxx
xxxxxxxxx xxxx% x x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxx x% x x x x xxxxx
xxxx x% x xx x x xxxx
xxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxx xxxxxx% xxxx x xxxxx xxxxx xxx
xxxx xxxxxxx% x xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxx xxxxxxx% xxx x xxxxx xxxxx xxxx
xxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx x xxxxx
xxxxxxxxxxxx xxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx xx xxxxx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx x
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx x
xxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxx xxxxxxxx% x x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx x
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxx% xxxx xx xxxx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx